Related Experiment Video
Updated: Apr 11, 2026
10:25
"Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection
Published on: February 19, 2019
12.3K
Hepatitis C: New challenges in liver transplantation
Tajana Filipec Kanizaj1, Nino Kunac1
1Tajana Filipec Kanizaj, Department of Gastroenterology, University Hospital Merkur, School of Medicine, University of Zagreb, 10000 Zagreb, Croatia.
World Journal of Gastroenterology
|May 29, 2015
Summary
Hepatitis C viral infection (HCV) significantly impacts liver transplantation outcomes, with recurrence common post-transplant. Novel antiviral therapies offer improved efficacy and safety for this challenging patient group.
Area of Science:
- Hepatology and Transplant Surgery
- Virology and Infectious Diseases
Background:
- Hepatitis C viral infection (HCV) is a primary driver for liver transplantation globally.
- Post-transplant recurrence of HCV is nearly universal in patients with detectable pre-transplant viremia, diminishing transplant success.
Discussion:
- Factors influencing HCV recurrence post-liver transplant, including donor, recipient, and viral characteristics, require further elucidation.
- Antiviral therapy is crucial but challenging in cirrhotic patients awaiting or undergoing transplantation.
Key Insights:
- Recent advancements in antiviral regimens demonstrate superior sustained viral response rates and improved safety profiles compared to older treatments.
- Optimizing antiviral strategies is essential for mitigating HCV recurrence and improving long-term outcomes after liver transplantation.
Outlook:
- Future research should focus on refining and implementing novel, safer, and more effective antiviral protocols for HCV-infected liver transplant recipients.
- Personalized treatment approaches may further enhance outcomes by considering individual patient and viral factors.
Keywords:
Direct acting antiviralsHepatitis CLiver transplantationPegylated interferonRibavirinTreatment protocolsMore Related Videos
Related Concept Videos
01:25Hepatitis
55
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
55
01:24Tissue Transplantation
1.3K
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
1.3K
01:28Kidney Transplant I: Introduction
749
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
749
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
347
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
347